Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer.

We constructed novel hypoxia- and lactate metabolism-related molecular subtypes and revealed their immunological and genetic characteristics. We also developed an HLM scoring system that could be used to predict the prognosis and efficacy of immunotherapy in patients with CRC.